Kestra Advisory Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Kestra Advisory Services's PACB Position: Q3 2026 in Review
Kestra Advisory Services increased its Pacific Biosciences (PACB) stake by 1.4% in Q3 2026, buying an estimated $706 and bringing the position to 35,798 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.
Kestra Advisory Services first reported a position in PACB in Q3 2025 and has held it in 5 quarters since. 204 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Kestra Advisory Services held 35,798 shares of Pacific Biosciences worth $84.8K as of Q3 2026.
- Kestra Advisory Services bought 500 Pacific Biosciences shares in Q3 2026, an estimated $706.
- Pacific Biosciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3366 holding.
- Kestra Advisory Services first reported a position in Pacific Biosciences in Q3 2025 and has held it in 5 quarters since.
- 204 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.